Nonmelanoma Deri Kanserleri: Bazal Hücreli Kanser Ve Skuamöz Hücreli Kanser

Year 2016, Volume: 8 Issue: 6, 36 - 41, 01.12.2016

Ülker Gül

Abstract

Nonmelanoma deri kanserleri (NMDK) sık gözlenen deri tümörleridir. Bu başlık altında

2 deri kanseri yer almaktadır: Bazal hücreli kanser (BHK) ve skuamöz hücreli kanser

(SHK). BHK, insanlarda gözlenen tüm kanserler içinde görülen en sık kanser türüdür.

SHK ise ikinci en sık deri kanseridir. BHK’nın SHK’ya oranı 4/1’dir. Bu yazıda BHK

ve SHK’in epidemiyolojisi, klinik tipleri ve tedavisi ile; genel olarak NMDK’in etyolojik

risk faktörleri anlatılacaktır.

Keywords

Nonmelanoma deri kanserleri, bazal hücreli kanser, skuamöz hücreli kanser

References

• 1. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375(9715):673-85. 2. Carucci JA, Leffell DJ. Basal Cell Carcinoma. In: Wolff K et al. Fitzpatrick’s Dermatology in General Medicine, 7th edition. USA. McGraw Hill Medical; 2008: 1036-42. 3. Wu PA. Epidemiology and clinical features of basal cell carcinoma. https://www.uptodate.com/contents/epidemiologyand- clinical-features-of-basal-cell-carcinoma 4. Bagheri MM, Safai B. Cutaneous malignancies of keratinocytic origin. Clin Dermatol. 2001;19(3):244-52. 5. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147(1):41-7. 6. McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol. 1997;133(5):593-6. 7. Leman JA, McHenry PM. Basal cell carcinoma: still an enigma. Arch Dermatol. 2001;137(9):1239-40. 8. Serrano H, Scotto J, Shornick G, Fears TR, Greenberg ER. Incidence of nonmelanoma skin cancer in New Hampshire and Vermont. J Am Acad Dermatol. 1991;24(4):574-9. 9. Telfer NR, Colver GB, Morton CA. British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159(1):35-48. 10. Lim JL, Asgari M. Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC). https://www.uptodate.com/contents/clinical-features-and-diagnosis- of-cutaneous-squamous-cell-carcinoma-scc 11.Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer. 1993 Feb 20;53(4):585-90. 12. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol. 2000;143(6):1224-9. 13. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26:467-84. 14. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4-7. 15. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975-83. 16. Grossman D, Leffell DJ. Squamous cell carcinoma. In: Wolff K et al. Fitzpatrick’s Dermatology in General Medicine, 7th edition. USA. McGraw Hill Medical; 2008: 1028-36. 17. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;26(1):1-26. 18. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975-83. www.kliniktipdergisi.com 41 19. Urbach F. Environmental risk factors for skin cancer. Recent Results Cancer Res. 1993;128:243-62. 20.Woodhead AD, Setlow RB, Tanaka M. Environmental factors in nonmelanoma and melanoma skin cancer. J Epidemiol. 1999 Dec;9(6 Suppl):S102-14. 21. Strom SS, Yamamura Y. Epidemiology of nonmelanoma skin cancer. Clin Plast Surg. 1997;24(4):627-36. 22. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146 Suppl 61:1-6. 23. Shore RE. Overview of radiation-induced skin cancer in humans. Int J Radiat Biol. 1990;57(4):809-27. 24. Karagas MR, Stukel TA, Greenberg ER, ve ark. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA. 1992;267(24):3305-10. 25.Marghoob A, Kopf AW, Bart RS, ve ark. Risk of another basal cell carcinoma developing after treatment of a basal cell arcinoma. Am Acad Dermatol. 1993;28(1):22-8. 26. Gawkrodger DJ. Occupational skin cancers. Occup Med (Lond). 2004;54(7):458-63. 27. Hogan DJ, To T, Gran L, ve ark. Risk factors for basal cell carcinoma. Int J Dermatol. 1989;28(9):591-4. 28. Corona R, Dogliotti E, D'Errico M, ve ark. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol. 2001;137(9):1162-8. 29. Gherardini G, Bhatia N, Stal S. Congenital syndromes associated with nonmelanoma skin cancer. Clin Plast Surg. 1997;24(4):649-61. 30. Kennedy C, Bajdik CD, Willemze R, ve ark. Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin. Br J Dermatol. 2005;152(1):194-7.